Abstract:Introduction Peritoneal dialysis (PD) is recognized as an effective treatment for patients with end-stage renal failure. Conventional PD solutions are unphysiological, as they contain bio-incompatible concentrations of glucose to provide the osmotic drive (Popovich et al. 1978) Thus, with increasing duration on PD, the peritoneum undergoes progressive structural and functional deterioration. Diabetiform alterations of the peritoneum, for example, the reduplication of the basement membrane, and increased matrix accumulation and deposition within the submesothelium are commonly observed in PD patients. These changes are mediated in part through activation of PKC and induction of TGF-β1 (Ha et al. 2001). Emodin (3-methyl-1,6,8 trihydroxyanthraquinone) has previously been demonstrated to reduce cell proliferation and fibronectin synthesis in cultured mesangial cells (Kuo et al. 2001; Yao et al. 1994). How emodin modulates glucose-induced fibronectin synthesis in human peritoneal mesothelial cells (HPMCs) has not been elucidated and thus constitutes the aim of this study. Materials and methods Confluent growth-arrested HPMCs were cultured under physiological (5 mm) or elevated (30 mm) d-glucose concentrations in the presence or absence of emodin (20 µg/ml) for periods up to 72 h. PKC-α activation in HPMCs cultured under control and experimental conditions was determined by Western blot analysis of cytosolic and cell membrane extracts. Synthesis of fibronectin and TGF-β1 was investigated by a combination of ELISAs, immunohistochemistry and Western blot analysis. Mannitol was used as the hexose control. Results Exposure of HPMCs to 30 mm d-glucose resulted in the activation of PKC-α commencing 12 h after stimulation, as demonstrated by the translocation of PKC-α from the cytosol to the cell membrane. Maximum induction of PKC-α was observed 48 h after stimulation and increased 1.4-fold and 3.7-fold in the cytosolic and membrane fractions, respectively, compared to 5 mm d-glucose. Activation of PKC-α was accompanied by the induction of TGF-β1 secretion in a time-dependent manner (3.72 ± 0.29 and 4.30 ± 0.50 pg/µg cellular protein at 24 h and 48 h, respectively, for 30 mm d-glucose compared to 2.13 ± 0.23 and 2.65 ± 0.32 pg/µg cellular protein at 24 h and 48 h, respectively, for 5 mm d-glucose, P < 0.001 at both time points) and increased fibronectin synthesis. Whilst emodin had no effect on constitutive PKC-α, TGF-β1 or fibronectin synthesis, emodin abrogated elevated glucose stimulation of PKC-α, and decreased TGF-β1 secretion and fibronectin synthesis to basal levels. Discussion Our findings demonstrate that emodin can ameliorate the undesirable effects of concentrated glucose on HPMCs through the suppression of PKC-α activation. This study suggests that emodin may have therapeutic potential in the prevention or treatment of glucose-induced structural and functional abnormalities in the peritoneal membrane.

Effect of ceramide on peritoneal mesothelial cells apoptosis induced by peritoneal dialysis solution

Investigation of the Apoptosis of Cultured Human Peritoneal Mesothelial Cells Induced by Peritoneal Dialysis Solution

Effects of Short Hairpin RNAs on TGF-β1 Expression and Ultrastructure in HPMCs Induced by Peritoneal Dialysis Solution

Advanced Glycation End Products Facilitate Proliferation and Reduce Early Apoptosis of Cardiac Microvascular Endothelial Cell Via PKCβ Signaling Pathway: Insight from Diabetic Cardiomyopathy

Effects of Astragalus on the apoptosis of cultured human peritoneal mesothelium induced by peritoneal dialysis solution

Puerarin protects the cultured human peritoneal mesothelial cells from the damage caused by peritoneal dialysate

Disruption of Low Density Lipoprotein Receptor Pathway is Involved in Peritoneal Fibrosis Induced by High Glucose Peritoneal Dialysis Solution

Effects of Tanshinone Ⅱ A on MMP-2 and TIMP-1 in Continuous Ambulatory Peritoneal Dialysis Patients

Effects of tanshinoneⅡA on oxidative stress and apoptosis cytokine expression of human peritoneal mesothelial cells

Effects of Tanshinone IIA on Oxidative Stress and Apoptosis-Related Cytokine Expressions of Human Peritoneal Mesothelial Cells

Emodin Ameliorates Glucose-Induced Morphologic Abnormalities and Synthesis of Transforming Growth Factor Beta 1 and Fibronectin by Human Peritoneal Mesothelial Cells

Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship

Cytotoxicity and Apoptotic Effect of Phytoceramide IV Containing Liposomes on Murine Mastocytoma Cell P815

Diabetic Patients Could Do As Well As Non-Diabetic Patients Without Inflammation on Peritoneal Dialysis

Melatonin decreases GSDME mediated mesothelial cell pyroptosis and prevents peritoneal fibrosis and ultrafiltration failure

Propofol pretreatment reduces ceramide production and attenuates intestinal mucosal apoptosis induced by intestinal ischemia/reperfusion in rats.

Emodin ameliorates glucose-induced fibronectin synthesis in human peritoneal mesothelial cells by inhibiting PKC-α activation

Protective Paracrine Effect of Mesenchymal Stem Cells on Cardiomyocytes

Expression and significance of SIRT6 in human peritoneal dialysis effluents and peritoneal mesothelial cells

Glucose Induces ER Stress Response-Mediated Peritoneal Mesothelial Cell Death

Influence of Bicarbonate/Low-GDP Peritoneal Dialysis Fluid (Bicavera) on in Vitro and Ex Vivo Epithelial-to-Mesenchymal Transition of Mesothelial Cells